Pair page
Argireline with SNAP-8
Mechanism-tag overlap and published literature for Argireline and SNAP-8, pulled verbatim from each Kalios compound profile. Kalios is a literature reference, not a recommendation.
Mechanism overlap
Mechanism tags are verbatim labels on each compound's profile. Generic tags ("peptide", "small-molecule", "research-chemical") are excluded from this overlap view. Tags are descriptive — not an inference about combined effect.
cosmetic-peptidesnap-25-mimetic
topical-cosmetic-snare-complex-mimetic
Co-administration notes from the literature
Verbatim summary text pulled from each compound's profile data. Researchers studying Argireline and SNAP-8 have published these mechanism-level observations. Not a co-administration recommendation.
An octapeptide extension of the Argireline N-terminal mimetic concept, developed by Lipotec as a putative next-generation sibling with higher binding affinity to the SNARE complex. Combination products market SNAP-8 as complementary rather than replacement. Head-to-head efficacy comparisons are limited to in vitro assays.
Quick facts
Argireline
SNAP-8
Literature table
Classified references from each compound profile. Click a column header to sort. Click a PMID to open PubMed. Findings are quoted verbatim from each profile's literature_summary; nothing here is added or interpreted.
| Year | Compound | Source | Finding |
|---|---|---|---|
| 2025 | Argireline | Zdrada-Nowak J, Surgiel-Gemza A, Szatkowska M. Acetyl Hexapeptide-8 in Cosmeceuticals — A Review of Skin Permeability and Efficacy. Int J Mol Sci. 2025 Jun 14;26(12):5722. doi: 10.3390/ijms26125722. PMID: 40565185. (Most recent systematic review; formulation science is the domin… PMID 40565185 | systematic review |
| 2019 | Argireline | Choi SY, Kwon HJ, Ahn GR, Ko EJ, Yoo KH, Kim BJ, Lee C, Kim D. Anti-Wrinkle Efficacy of Cross-Linked Hyaluronic Acid-Based Microneedle Patch with Acetyl Hexapeptide-8 and Epidermal Growth Factor on Korean Skin. Ann Dermatol. 2019 Jun;31(3):263-271. doi: 10.5021/ad.2019.31.3.263.… PMID 33911590 | human trial |
| 2017 | Argireline | Raikou V, Varvaresou A, Panderi I, Papageorgiou E. The efficacy study of the combination of tripeptide-10-citrulline and acetyl hexapeptide-3. A prospective, randomized controlled study. J Cosmet Dermatol. 2017 Jun;16(2):271-278. doi: 10.1111/jocd.12314. PMID: 28150423. (Four-ar… PMID 28150423 | human trial |
| 2013 | Argireline | Wang Y, Wang M, Xiao S, Pan P, Li P, Huo J. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013 Apr;14(2):147-153. doi: 10.1007/s40257-013-0009-9. PMID: 23417317. (The largest ran… PMID 23417317 | human trial |
| 2013 | Argireline | Lungu C, Considine E, Zahir S, Ponsati B, Arrastia S, Hallett M. Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. Eur J Neurol. 2013 Mar;20(3):515-518. doi: 10.1111/ene.12009. PMID: 23146065. (NIH / NIN… PMID 23146065 | human trial |
| 2002 | Argireline | Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernández-Ballester G, Ponsati B, Gutierrez L, Pérez-Payá E, Ferrer-Montiel A. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002 Oct;24(5):303-310. doi: 10.1046/j.1467-2494.2002.00153.x. PMID: 184985… PMID 18498523 | human pilot |
| 2013 | Argireline | Wang Y, Wang M, Xiao XS, Pan P, Li P, Huo J. The anti wrinkle efficacy of synthetic hexapeptide (Argireline) in Chinese Subjects. J Cosmet Laser Ther. 2013 Aug;15(4):237-241. doi: 10.3109/14764172.2013.769273. PMID: 23607739. (Companion murine / clinical paper — D-galactose-aged… PMID 23607739 | preclinical, in vivo |
| 2015 | Argireline | Kraeling MEK, Zhou W, Wang P, Ogunsola OA. In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutan Ocul Toxicol. 2015 Mar;34(1):46-52. doi: 10.3109/15569527.2014.894521. PMID: 24754410. (Independent FDA in vitro penetration study — ~0.22% of 10% appl… PMID 24754410 | preclinical, in vitro |
| 2021 | Argireline | Lim SH, Kathuria H, Amir MHB, Zhang X, Duong HTT, Ho PCL, Kang L. High resolution photopolymer for 3D printing of personalised microneedle for transdermal delivery of anti-wrinkle small peptide. J Control Release. 2021 Jan 10;329:907-918. doi: 10.1016/j.jconrel.2020.10.021. PMID… PMID 33068646 | pharmacology |
| 2020 | Argireline | Errante F, Ledwoń P, Latajka R, Rovero P, Papini AM. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020 Oct 26;8:572923. doi: 10.3389/fchem.2020.572923. PMID: 33195060. (Contextual review of cosmetic-peptide biochemistry and categorisation;… PMID 33195060 | review |
| 2024 | Argireline | Public Interest in Acetyl Hexapeptide-8: Longitudinal Analysis. JMIR Dermatol. 2024;7:e54217. doi: 10.2196/54217. PMID: 38376906. (Google Trends analysis 2013-2023; post-2022 TikTok-driven consumer search surge; coining of "Botox in a bottle" in popular culture.) PMID 38376906 | research article |
| 2020 | Argireline | Lim SH, Tiew WJ, Zhang J, Ho PC, Kachouie NN, Kang L. Geometrical optimisation of a personalised microneedle eye patch for transdermal delivery of anti-wrinkle small peptide. Biofabrication. 2020;12(3):035003. doi: 10.1088/1758-5090/ab6d37. PMID: 31952064. (3D-printed personalis… PMID 31952064 | research article |
| 2002 | SNAP-8 | Blanes-Mira C, Clemente J, Jodas G, Gil A, Fernández-Ballester G, Ponsati B, Gutierrez L, Pérez-Payá E, Ferrer-Montiel A. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002;24(5):303-310. PMID: 18498522. (Argireline characterization — direct p… PMID 18498522 | mechanism / discovery |
| — | SNAP-8 | Molecular modeling elucidates the cellular mechanism of synaptotagmin-SNARE inhibition: a novel plausible route to anti-wrinkle activity of botox-like cosmetic active molecules. (Computational binding characterization.) | mechanism / discovery |
| 2022 | SNAP-8 | FDA. Modernization of Cosmetics Regulation Act (MoCRA). fda.gov. 2022. (U.S. cosmetic-regulation framework applicable to SNAP-8-containing products.) | regulatory / registry |
| 2016 | SNAP-8 | Zhang Y, Xu Q, Zhuang C. Synthesis and preliminary evaluation of the anti-wrinkle effect of acetyl octapeptide-3 (SNAP-8). Chin J Dermatol. 2016;49(8):593-596. (Chinese dermatology journal report on SNAP-8 — one of the few peer-reviewed non-manufacturer SNAP-8 studies.) | industry documentation |
| — | SNAP-8 | Lipotec S.A. / Grupo LUBRIZOL. SNAP-8™ (Acetyl Octapeptide-3) product documentation and in-vivo manufacturer studies. (Foundational in-vitro SNARE-complex characterization and 4% / 28-day in-vivo cosmetic efficacy data — industry sponsor documentation.) | industry documentation |
| 2013 | SNAP-8 | Wang Y, Wang M, Xiao XS, Huo J, Zhang WD. The anti-wrinkle efficacy of Argireline. J Cosmet Laser Ther. 2013;15(4):237-241. PMID: 23472662. (Argireline efficacy data providing comparator context for SNAP-8.) PMID 23472662 | research article |
| 2012 | SNAP-8 | Jahn R, Fasshauer D. Molecular machines governing exocytosis of synaptic vesicles. Nature. 2012;490(7419):201-207. PMID: 23060190. (SNARE-complex mechanistic review.) PMID 23060190 | research article |
| 2010 | SNAP-8 | Montal M. Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem. 2010;79:591-617. PMID: 20233039. (Botulinum toxin / SNAP-25 mechanism — comparator framework for SNAP-8.) PMID 20233039 | research article |
| 2009 | SNAP-8 | Sudhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. Science. 2009;323(5913):474-477. PMID: 19164740. (Foundational SNARE-complex biology — Nobel Prize context for the mechanism SNAP-8 targets.) PMID 19164740 | research article |
| 2007 | SNAP-8 | Dressler D, Benecke R. Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil. 2007;29(23):1761-1768. PMID: 18033603. (Injected botulinum toxin clinical pharmacology — comparator for SNAP-8 topical claims.) PMID 18033603 | research article |
| 2007 | SNAP-8 | Ruiz MA, Clares B, Morales ME, Cazalla S, Gallardo V. Preparation and stability of cosmetic formulations with an anti-aging peptide. J Cosmet Sci. 2007;58(2):157-171. PMID: 17520181. (Cosmetic formulation chemistry for peptide actives.) PMID 17520181 | research article |
Related pair pages
More research context
Frequently asked
Have Argireline and SNAP-8 been studied together?
Researchers have published mechanistic-level co-administration discussion of Argireline and SNAP-8. No human co-administration trials are catalogued in the Kalios profiles. The pair page lists each compound's classified literature; full citations sit on each individual profile.
What mechanisms do Argireline and SNAP-8 share?
Argireline and SNAP-8 do not share a specific mechanism tag on their Kalios profiles. They appear on the same pair page because at least one profile lists the other in its co-administration data.
What is the FDA status of Argireline and SNAP-8?
Argireline: Cosmetic ingredient (not a drug). SNAP-8: Cosmetic ingredient only. FDA-status text is pulled verbatim from each compound profile. See /fda-pcac-2026.html for the broader FDA Pharmacy Compounding Advisory Committee context.
Where can I find the full research on Argireline and SNAP-8?
Full citation lists, dosing tables from the literature, reconstitution data, and the FDA / WADA status are on the individual compound profiles: the Argireline profile and the SNAP-8 profile. The Kalios Stack Research Tool hub lists every compound covered.
Last updated: April 2026